Manthanam Pharmaceutical Private Limited

In their own words

The company Manthanam Pharmaceuticals Private Limited was founded on the desire to find and distribute effective new medicines. One of Manthanam Pharmaceuticals' most valuable assets and competitive advantages is the company's established track record in all major therapeutic areas, including gynaecology, cardiology, blood-related illnesses, cancer, respiratory disorders, central nervous system disorders, and HIV. We have introduced bio-similar both domestically and globally and have become the market leader for a number of biologics. Clinical trials of an mRNA vaccine against COVID-19 are currently underway in India, and our team is responsible for producing the vaccine. With the help of our cutting-edge API facilities, we have better control over the manufacturing process without compromising on flexibility, thus contributing to the vertical integration of our supply chain. Our strategic partnerships with local and multinational corporations that are industry leaders in key therapeutic areas have allowed us to establish global strategic links. Our expansion around the world is motivated by our mission to deliver cutting-edge medical services to patients at affordable prices.

Written by the company on its public Startup India profile. Not verified by us.